Ferric Ammonium Citrate
drugOn this page
Also known as Ammonium ferric citrateE 381E-381browngreenFerriseltzIns no.381Ins-381
Summary
Ferric Ammonium Citrate (CHEMBL4301175) is an approved small molecule (ATC V08CA07).
At a glance
- Status: Approved (max clinical phase 4)
- Modality: Small molecule
- ATC class: V08CA07
- Clinical trials: 1
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL4301175 |
| Name | Ferric Ammonium Citrate |
| Type | Small molecule |
| Max phase | 4 |
| ATC | V08CA07 |
Also known as: Ammonium ferric citrate, E 381, E-381, Ferric ammonium citrate, brown, green, Ferriseltz, Ins no.381, Ins-381, FERRIC AMMONIUM CITRATE
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
0 indications (0 at ChEMBL trial phase 4).
Clinical trials
Total trials: 1.
Phase distribution
| Phase | Trials |
|---|---|
| Not specified | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT04721964 | Not specified | COMPLETED | Evaluation of the Effects of Routine Iron Supplementation in Children on Gastrointestinal Iron Losses |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.